MicroBiome Therapeutics: Reducing Side-Effects of Drugs Like Metformin


Earlier this year, Colorado-based MicroBiome Therapeutics kicked off a round of funding to finance a drug intended to improve the tolerability of Metformin (also known as Glucophage), a popular diabetes drug with numerous side-effects. If this drug, a reformulation of Metformin know as NM505 , is successful, it will provide relief to the approximately 50% of Metformin patients who experience diarrhea from the drug and the approximately 25% of patients who experience vomiting. Read more at: http://medcitynews.com/2015/04/colorado-startups-microbiome-modulating-drug-improve-metformin-tolerability/?rf=1 or http://www.mbiome.com/.


Published by

Dave Bove

Innovation Lover, Singer, Actor, Songwriter, Guitarist (poor one), Artist, Computer Geek, and Jolly (sometimes) Rancher...

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s